Wanbang

Sirona Biochem signs international partnership agreement with Wanbang Biopharmaceuticals

Sirona Biochem Corp. VANCOUVER, British Columbia, November 23, 2022 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces that, following the LOI, Sirona and Wanbang Biopharmaceuticals (“Wanbang”) signed an expanded international partnership agreement to collaborate on the licensing of Sirona’s SGLT2 inhibitor, TFC-039, as a pharmaceutical treatment for animal and […]

Scroll to top